Intensity-modulated radiotherapy outcomes for oropharyngeal squamous cell carcinoma patients stratified by p16 status.
about
p16, Cyclin D1, and HIF-1α Predict Outcomes of Patients with Oropharyngeal Squamous Cell Carcinoma Treated with Definitive Intensity-Modulated Radiation Therapy.Prognostic factors in limited (T1-2, N0-1) oropharyngeal carcinoma treated with surgery ± adjuvant therapy.The Contrasting Role of p16Ink4A Patterns of Expression in Neuroendocrine and Non-Neuroendocrine Lung Tumors: A Comprehensive Analysis with Clinicopathologic and Molecular CorrelationsPatterns of Relapse in Squamous Cell Carcinoma of the Tonsil - Unilateral vs. Bilateral Radiation in the HPV-Era.Predictive value of human papillomavirus in oropharyngeal carcinoma treated with radiotherapy: An updated systematic review and meta-analysis of 30 trials.Management of Recurrent and Metastatic HPV-Positive Oropharyngeal Squamous Cell Carcinoma after Transoral Robotic Surgery.Outcomes of intensity-modulated radiotherapy as primary treatment for oropharyngeal squamous cell carcinoma - a European singleinstitution analysis.The Neddylation Inhibitor Pevonedistat (MLN4924) Suppresses and Radiosensitizes Head and Neck Squamous Carcinoma Cells and Tumors.p16 status and interval neck dissection findings after a 'clinically complete response' to chemoradiotherapy in oropharyngeal squamous cell carcinoma.Intensity-modulated radiation therapy as primary treatment for oropharyngeal squamous cell carcinoma.RNA Oncoimmune Phenotyping of HPV-Positive p16-Positive Oropharyngeal Squamous Cell Carcinomas by Nodal Status.Management of the neck in the setting of definitive chemoradiation: is there a consensus? A GETTEC study.
P2860
Q30425570-60F196C1-0C63-4D7F-BAA4-61EA85C0483AQ34610943-7DB30721-30FD-4B77-A676-6394712B2054Q35870560-0A2755F8-CD07-4F16-A581-00E70ADC548FQ36148861-87CDC753-D67A-4349-8E09-3C45F6A9B21BQ38100754-3FB07731-504B-4FCF-9F46-145CF2CBACCAQ39218448-85BA914D-23FD-4627-B3CB-27AE4AE1BBD9Q39761858-3F8AC9DD-A42F-4CCD-9495-F627CA58FD6DQ40071281-E16DF0F6-9418-4F1D-A763-D85922E9A4F5Q40823048-5E456AFE-AA12-4098-A027-AD9A4870BB63Q44506873-0481DEB3-0675-4741-80F1-AE817587F18AQ52715554-01106F99-E857-4018-8116-C2944A7C50BAQ53171946-A51F32E5-D2DE-41C0-BA75-9BCCB2D798CB
P2860
Intensity-modulated radiotherapy outcomes for oropharyngeal squamous cell carcinoma patients stratified by p16 status.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Intensity-modulated radiothera ...... ents stratified by p16 status.
@ast
Intensity-modulated radiothera ...... ents stratified by p16 status.
@en
type
label
Intensity-modulated radiothera ...... ents stratified by p16 status.
@ast
Intensity-modulated radiothera ...... ents stratified by p16 status.
@en
prefLabel
Intensity-modulated radiothera ...... ents stratified by p16 status.
@ast
Intensity-modulated radiothera ...... ents stratified by p16 status.
@en
P2093
P2860
P356
P1433
P1476
Intensity-modulated radiothera ...... ents stratified by p16 status.
@en
P2093
Asal Shoushtari
Christopher Y Thomas
James F Reibel
Kimberly Keene
Mark J Jameson
Mathew Meeneghan
Paul A Levine
Paul W Read
P2860
P304
P356
10.1002/CNCR.25040
P407
P577
2010-06-01T00:00:00Z